Screening for obstructive lung disease in hospitalized psychiatric patients

References

• Lõpez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23.
   PubMed Web of Science ®Google Scholar
• Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–1544.
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582.
   PubMed Web of Science ®Google Scholar
• Wahlbeck K, Westman J, Nordentoft M, et al. Outcomes of Nordic mental health systems: life expectancy of patients with mental disorders. Br J Psychiatry. 2011;199(6):453–458.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Nordentoft M, et al. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. J Clin Psychiatry. 2007;68(06):899–907.
   PubMedGoogle Scholar
• Lores L, Monje A, Bergada M, et al. Prevalence of smoking in a psychiatric hospital and its relationship with respiratory symptoms and the prevalence of COPD. COPD. 2018;13:2797–2804.
   Google Scholar
• León-Gómez BB, Colell E, Villalbí JR, et al. Impact of smoke-free regulations on smoking prevalence trends in Spain. Eur J Public Health. 2017;27(1):123–128.
   PubMed Web of Science ®Google Scholar
• Lokke A, Fabricius PG, Vestbo J, et al. Prevalence of chronic obstructive pulmonary disease in Copenhagen. Results from The Copenhagen City Heart Study. Ugeskr Laeger. 2007;169(46):3956–3960.
   PubMedGoogle Scholar
• Lokke A, Ulrik CS, Dahl R, et al. Detection of previously undiagnosed cases of COPD in a high-risk population identified in general practice. COPD J Chronic Obstr Pulm Dis. 2012;9(5):458–465.
   Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338.
   PubMed Web of Science ®Google Scholar
• Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J. 2005;26(1):153–161.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Glob Initiat Asthma [Internet]; 2017. [cited 2019 Oct 31]. Available from: http://ginasthma.org/2017-gina-report-global-strat; www.ginasthma.org
   Google Scholar
• Ir WS, Ghobadi H, Ahari SS, et al. The Relationship between COPD Assessment Test (CAT) scores and severity of airflow obstruction in stable COPD patients. Tanaffos. 2012;11(2):22–26.
   PubMedGoogle Scholar
• Baxter AJ, Harris MG, Khatib Y, et al. Reducing excess mortality due to chronic disease in people with severe mental illness: meta-review of health interventions. Br J Psychiatry. 2016;208(4):322–329.
   PubMed Web of Science ®Google Scholar
• Nordentoft M, Wahlbeck K, Hallgren J, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One. 2013;8(1):e55176.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011;6(9):e24597.
   PubMed Web of Science ®Google Scholar
• Šagud M, Mihaljević-Peleš A, Mück-Šeler D, et al. Smoking and schizophrenia. Psychiatria Danub. 2009;21:371–375.
   PubMed Web of Science ®Google Scholar
• Oud MJT, Meyboom-de Jong B. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract. 2009;10(1):32.
   PubMedGoogle Scholar
• Alam A, Michael Huijon R, Alla V, et al. COPD comorbid with mental illness: what psychiatrists can do: you can do a great deal to ease patients’ pulmonary distress as you manage their psychiatric illness. Curr Psychiatr. 2016;15(5):68–74.
   Google Scholar
• Crump C, Winkleby MA, Sundquist K, et al. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324–333.
   PubMed Web of Science ®Google Scholar
• Dacanay J, Limpin ME. Accuracy of handheld spirometry as a comparable diagnostic tool to pulmonary function testing. Chest. 2013;144(4):833A.
   Web of Science ®Google Scholar
• Kerwin EM, Hickey L, Small CJ. Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone. Respir Med. 2019;151(March):35–42.
   PubMedGoogle Scholar
• Ho T, Cusack RP, Chaudhary N, et al. Under- and over-diagnosis of COPD: a global perspective. Breathe. 2019;15(1):24–35.
   Web of Science ®Google Scholar
• Backer V, Sverrild A, Ulrik CS, et al. Diagnostic work-up in patients with possible asthma referred to a university hospital. Eur Clin Respir J. 2015;2(1):27768.
   PubMed Web of Science ®Google Scholar
• Rosen-Reynoso M, Alegría M, Chen CN, et al. The relationship between obesity and psychiatric disorders across ethnic and racial minority groups in the United States. Eat Behav. 2011;12(1):1–8.
   PubMed Web of Science ®Google Scholar
• Salome CM, King GG, Berend N. Physiology of obesity and effects on lung function. J Appl Physiol. 2010;108(1):206–211.
   PubMed Web of Science ®Google Scholar
• Al Ghobain M. The effect of obesity on spirometry tests among healthy non-smoking adults. BMC Pulm Med. 2012;12(1):10.
   PubMedGoogle Scholar
• Ali Z, Ulrik CS. Obesity and asthma: a coincidence or a causal relationship? A systematic review. Respir Med. 2013;107(9):1287–1300.
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–781.
   PubMed Web of Science ®Google Scholar
• Buhl R, Maltais F, Abrahams R, et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4). Eur Respir J. 2015;45(4):969–979.
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Vogelmeier C, Pieper MP, et al. Effect of tiotropium on COPD exacerbations: a systematic review. Respir Med. 2016;114:1–8.
   PubMed Web of Science ®Google Scholar